Table 1 Basic characteristics of patients undergoing major emergency abdominal surgery
Characteristics | Whole cohort (n = 83) |
|---|---|
Age; years | 64.1 (15.8) |
Male | 44 (53.0%) |
BMI | 25.3 (5.4) |
Smoking (no/former/active) | 35 (42.1%)/32 (38.6%)/16(19.3%) |
Alcohol (none, ≤ 7 units/week, > 7 units/week) | 35 (42.2%)/27 (32.5%)/21 (25.3%) |
Preoperative sBP/dBP; mmHg | 140.3 (22.2)/78.9 (13.0) |
Hemoglobin; g.dl−1 | 13.4 (2.7) |
Leucocytes; × 109.l−1 | 12.6 (6.3) |
CRP; mg.l−1 (median (IQR)) | 11.0 (54.0) |
Thrombocytes; × 109.l−1 | 283.6 (118.0) |
Creatinine; mg.dl−1 | 0.93 (0.43) |
Albumin; g.l−1 | 35.0 (6.9) |
Cardiovascular risk factors | |
Ischemic heart disease | 7 (8.4%) |
Atrial fibrillation | 5 (6.0%) |
Hypertension | 26 (31.3%) |
Congestive heart failure | 3 (3.6%) |
Peripheral arterial disease | 6 (7.2%) |
Cerebrovascular disease | 5 (6.0%) |
Diabetes | 6 (7.2%) |
RCRI (1/2/≥3) | 67 (80.7%)/13 (15.7%)/3 (3.6%) |
ASA (1–2/3–4) | 52 (62.7%)/31 (37.3%) |
Performance score (0–1/2–3) | 79 (95.2%)/4 (4.8%) |
Preoperative medication | |
Acetylsalicylic acid | 17 (20.5%) |
Statin | 14 (16.9%) |
ADP-receptor inhibitors | 9 (10.8%) |
Anticoagulation | 5 (6.0%) |
Beta blockers | 7 (8.4%) |
Calcium channel blockers | 9 (10.8%) |
Diuretics | 20 (24.1%) |
ACE-I/ARBs | 18 (21.7%) |
Antidiabetics (per oral)/Insulin | 4 (4.8%)/2 (2.4%) |
Assessment of endothelial function, hrs. from end of operation | |
Assessment 1 (4–24 h) | 15.8 (6.9) |
Assessment 2 (POD3–5) | 83.7 (19.8) |